Among the issues raised by stakeholders during fiscal tobacco in our retail pharmacies in the U.S. and Puerto Rico, our potential to help combat the opioid abuse crisis in the U.S., our potential to help affect health treatment outcomes through our pharmacies, our potential to impact the health of military veterans, the transparency and traceability of ingredients such as palm oil in our products, the protection of our customers’ data privacy and security, collaboration with institutions and other businesses to drive higher recycling rates in the U.S., and our corporate governance.